In addition to supporting 100+ innovator organizations in over 90 countries, Innovations in Healthcare leads and supports a rich portfolio of programs, together with the Duke Global Health Innovation Center, to support innovation and impact strategies, study innovation, and scale innovative healthcare organizations.

Scaling Innovative Healthcare Organizations

The products and services that address the most critical challenges in health care, and the organizations that develop, evaluate, and scale those solutions, need significant and long-term support to maximize their chance of success in reaching the most vulnerable populations and improving health. We bring to the table a rich knowledge base of practical know-how on best practices for scaling innovations through over a decade of study in the field.

  • Accelerating Saving Lives at Birth (ASL@B): ASL@B was an accelerator program that increased the scale, sustainability, and effectiveness of promising innovations in the Saving Lives at Birth Portfolio—with the overarching goal of improving maternal and newborn health (MNH) outcomes across the globe. The ASL@B program assisted 50+ innovations to scale through ongoing, individualized coaching and mentoring. Funded by USAID, NORAD, Bill & Melinda Gates Foundation, Grand Challenges Canada, DFID, and KOICA.
  • Improved Health of Underserved Filipinos (ReachHealth Philippines): ReachHealth was a five-year initiative to reduce unmet needs for family planning services and decrease teen pregnancy and newborn morbidity and mortality. In partnership with RTI, we designed and implemented an innovation platform to find and accelerate the best family planning and teenage pregnancy innovations. Funded by USAID through RTI International 
  • The Social Entrepreneurship Accelerator at Duke (SEAD): SEAD mobilized a community of practitioners, investors, policymakers, faculty, staff, and students to identify, assess, build the capacity of, and scale health and healthcare enterprises around the world. Through SEAD, a subset of Innovations in Healthcare innovators had the opportunity to participate in a rigorous program of engagement and evaluation designed to help them scale their impact. Funded by USAID
  • The Making More Health Venture4Change (MMH Venture4Change): MMH Venture4Change program provided entrepreneurship training and supported student teams to apply the learning through developing low-cost hygiene solutions for urban-poor and rural communities. This initiative was supported by Making More Health, a global initiative of Boehringer Ingelheim (BI) and implemented in partnership with two Kenyan universities - Strathmore University and Kenyatta University

Sharing Knowledge and Translating Insights 

We capture qualitative and quantitative metrics on individual entrepreneurs as well as at a portfolio level, and translate those into relevant insights and learnings. We regularly collect and analyze data across our network to identify trends in achieving impact at scale and use these findings to improve our program offerings.

  • Launch and Scale Speedometer: This initiative aims to build the evidence-base of the speed and pathways—from proof of concept to scale-up—of life-saving health technologies and interventions. The Launch and Scale Speedometer provides a robust set of metrics and deep insights to inform policymakers, product developers, and global health funders, of the key enablers and barriers to launch and scale up of these interventions in low- and middle-income countries. Funded by the Bill & Melinda Gates Foundation.
  • Market Landscape Analysis of Digital Health Tools in Asia-Pacific region: IiH developed comprehensive country profiles on digital health innovation in two therapeutic areas for four target markets in the Asia-Pacific region which included digital tools, expectation and demand by various stakeholders, and receptivity for digital health innovation. Funded by Amgen.  
  • Reverse Innovation: In partnership with the Duke Margolis Center for Health Policy, we examined 60+ global health systems and evaluated over 1,000 care delivery and payment reform innovations to identify solutions that could be rapidly adapted and scaled to strengthen US health systems targeting high-need, high-cost populations. Funded by The Commonwealth Fund.
  • Landscaping Study of Healthcare Delivery Innovation in China: A landscape study of healthcare innovation in China that analyzed fifteen models of healthcare innovation and provides insight into barriers to innovation in China’s healthcare delivery sector.  

Supporting Sustainable Access to Quality Healthcare

Innovations in Healthcare has studied and been involved in the implementation of several innovative programs to advance equitable access to healthcare. We have experience in the development and implementation of both private and public-sector programs and bring with us expertise in policy, financing, and measurement of evaluation of impact.

  • African Collaborative for Health Financing Solutions (ACS): ACS was a five year project working with regional bodies and country-level multi-stakeholder platforms to share knowledge, strengthen accountability and promote health financing policies and processes that advance UHC in sub-Saharan Africa. Led by Results for Development, ACS mobilizes a diverse team of African experts and international organizations to support learning and accountability for UHC at the national and regional level. Funded by USAID
  • Evaluating Saving Lives at Birth (ESL@B): In partnership with the Evidence Lab at the Duke Global Health Institute, Duke GHIC evaluated the Saving Lives at Birth Grand Challenge to determine if it was achieving its intended impact and to generate data-driven recommendations for future initiatives. Funded by USAID.
  • Global Health Innovation Grant Program (GHIG): In partnership with The Pfizer Foundation, IiH supports GHIG grantees by facilitating connections in the ecosystem and monitors and evaluates grantees’ performance to inform the Pfizer Foundation’s impact measurement and investment strategy. Funded by The Pfizer Foundation.
  • Impact and Evaluation Support to a Flagship Global Health Program: IiH provided impact and evaluation support to the multistakeholder Blueprint for Innovative Healthcare Access program operating in Meru County, Kenya. Together with the consortium partners, IiH guided the development of evaluation plans, delivered workshops on key topics to strengthen evaluation capacity, and routinely validated and analyzed data from all program partners to drive greater outcomes and data-oriented decision making. Funded by Takeda Pharmaceuticals Inc. 
  • Pharma Infectious Disease Initiative (IDI): Developed a longitudinal monitoring and evaluation strategy to guide the design, implementation, refinement, and impact tracking of the client’s Infectious Disease Initiative for maximum global impact. Designed evaluation framework anchored on a Theory of Change with clearly defined inputs and expected outputs and outcomes and intended impact in the long-term.
  • Research and Policy Analysis Support on Primary Healthcare Innovations in Kenya: IiH provided insights on adopting and scaling primary healthcare innovations in Kenya to support the achievement of Universal Health Coverage (UHC) in line with the SDG3 framework as well as the Government of Kenya’s Big Four Agenda and UHC Roadmap.The research was commissioned by Kenya’s Ministry of Health and the UNSDG Partnership Platform and funded by Takeda Pharmaceuticals, Inc.
  • Strengthening the Impact of Private-Sector Supported Global Health Programs: IiH analyzed the landscape of global biopharmaceutical company access to medicines initiatives and developed the Access to Health Impact Measurement Framework and a practical guidebook to support the design, measurement, and evaluation of these initiatives. Funded by Takeda Pharmaceuticals Inc.
  • Indian State Priorities for Health Innovation Partnerships: This project identified opportunities for Indian states to partner with international institutions on health strengthening. The team developed a clearer picture of India’s state-level health care reform priorities and identified specific areas for potential partnership across four categories: capacity building, organizational delivery, financing, and specific health conditions. Funded by Center for Strategic and International Studies (CSIS).